LOC145783 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.781000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.351800E-01
Normal-vs-Stage2
4.727400E-01
Normal-vs-Stage3
1.558960E-01
Normal-vs-Stage4
9.741000E-01
Stage1-vs-Stage2
2.453400E-01
Stage1-vs-Stage3
2.602200E-01
Stage1-vs-Stage4
9.430400E-01
Stage2-vs-Stage3
3.111600E-01
Stage2-vs-Stage4
3.893000E-01
Stage3-vs-Stage4
1.336560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.077000E-01
Normal-vs-AfricanAmerican
9.432800E-01
Normal-vs-Asian
1.233840E-01
Caucasian-vs-AfricanAmerican
3.061600E-01
Caucasian-vs-Asian
1.572830E-01
AfricanAmerican-vs-Asian
5.165600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.057600E-01
Normal-vs-Female
3.351000E-01
Male-vs-Female
1.948000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.648000E-01
Normal-vs-Age(41-60Yrs)
4.091600E-01
Normal-vs-Age(61-80Yrs)
3.404000E-01
Normal-vs-Age(81-100Yrs)
8.170200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.683600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.310000E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.558400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.949400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.976630E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.929240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.520000E-01
Normal-vs-Daily Drinker
5.906200E-01
Normal-vs-Weekly Drinker
6.441600E-01
Normal-vs-Occasional Drinker
6.481600E-01
Normal-vs-Social Drinker
5.056200E-01
Non Drinker-vs-Daily Drinker
9.961400E-01
Non Drinker-vs-Weekly Drinker
7.869800E-01
Non Drinker-vs-Occasional Drinker
7.785200E-01
Non Drinker-vs-Social Drinker
8.044200E-01
Daily Drinker-vs-Weekly Drinker
8.110200E-01
Daily Drinker-vs-Occasional Drinker
8.041800E-01
Daily Drinker-vs-Social Drinker
8.213000E-01
Weekly Drinker-vs-Occasional Drinker
9.936600E-01
Weekly Drinker-vs-Social Drinker
6.575600E-01
Occasional Drinker-vs-Social Drinker
6.459000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.310600E-01
Normal-vs-Grade 2
5.041400E-01
Normal-vs-Grade 3
3.474600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.174400E-01
Grade 1-vs-Grade 3
6.670000E-02
Grade 1-vs-Grade 4
5.310600E-01
Grade 2-vs-Grade 3
5.414100E-02
Grade 2-vs-Grade 4
5.041400E-01
Grade 3-vs-Grade 4
3.474600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.543400E-01
Normal-vs-NonDiabetic
5.066000E-01
Diabetic-vs-NonDiabetic
5.942800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.849400E-01
Normal-vs-NoPancreatitis
4.341600E-01
Pancreatitis-vs-NoPancreatitis
1.597250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.382800E-01
Normal-vs-N1
4.554600E-01
N0-vs-N1
7.663600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.883600E-01
Normal-vs-TP53-NonMutant
1.082050E-01
TP53-Mutant-vs-TP53-NonMutant
2.934000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
